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Introduction
In prostate cancer (PCa) treatment, the aim of retaining urinary continence and full sexual health after treatment is universal. Surgeons who perform radical prostatectomy (RP) continuously accumulate experience and develop their technical skills, resulting in improved urinary continence and sexual health [1] . The traditional surgical approach is open surgery (retropubic RP [RRP] ), on which the evidence for RP as a cure for PCa rests [2] . Over the past 20 yr, laparoscopic methods have been developed; however, reviews of clinical and oncologic outcomes do not favour laparoscopy over RRP [3, 4] . Robot-assisted laparoscopic prostatectomy (RALP) was introduced with the aim of improving surgical outcomes, but controlled or randomised studies on the long-term effects are few and present knowledge of effectiveness is based mainly on case series or registry data [4] [5] [6] [7] .
During RALP, the surgeon has a three-dimensional view of the operating field that should mimic open surgery better than the two-dimensional view with the laparoscopic technique. Performing RRP, the surgeon is guided by the use of external loupes and a headlight; RALP incorporates high-level resolution and enlarged images as well as excellent lighting conditions [8] . In open surgery, the surgeon uses digital palpation of the prostatic contours to identify anatomic landmarks and gain haptic feedback from the tissues, including a direct sense of traction force. These approaches cannot be used in the robot-assisted technique. Consequently, each technique is likely to have technical pros and cons that may reflect on postoperative urinary and sexual function.
We initiated a prospective, controlled, nonrandomised trial in which the intervention was RALP and the control was RRP. The short-term results have been reported with longer operating time, less blood loss during surgery, and shorter length of hospital stay for RALP compared with RRP [9] .
In this analysis, the aim was to determine patientreported urinary incontinence and erectile dysfunction 12 mo after RP performed by RRP or RALP.
Patients and methods
Details of patients and methods are shown in Supplement 1.
The Laparoscopic Prostatectomy Robot Open (LAPPRO) study had an open, prospective, controlled, nonrandomised study design and included patients from seven centres performing RALP, at which only 4% of the included radical prostatectomies were RRPs, and seven different centres performing RRP, at which RALP was not performed. To minimise differences between groups, we collected information on risk factors and made adjustments during analysis of the data. The design and data collection have been described previously [9, 10] .
The LAPPRO trial was registered with the ISRCTN (ISRCTN06393679).
The regional ethics review board in Gothenburg, Sweden, approved the study (approval 277-07).
All men diagnosed with PCa and scheduled for RP at 14 participating centres were screened for possible inclusion in the study (Fig. 1 ). For this analysis, patients had to meet the following inclusion criteria:
age <75 yr; ability to read and write Swedish; written informed consent; tumour stage cT1, cT2, or cT3; no signs of distant metastases; and prostate-specific antigen (PSA) concentration <20 ng/ml. To decrease the influence of the initial learning period in this analysis, we included only patients operated on by surgeons with experience of 100 procedures [11, 12] .
The primary end point was urinary incontinence 12 mo after surgery, as reported by the patients, in an attempt to decrease bias owing to patient-surgeon relationships [13] [14] [15] . The time point is appropriate, as little change was seen in continence later than 12 mo after surgery [16, 17] . The questionnaire used the same clinometric approaches as those used previously [18] [19] [20] [21] [22] . The questionnaire included 39 questions about urinary function, most of which have been used before [14, 23, 24] Table 2 ). The analyses did not include adjustment for treatment of erectile dysfunction.
The secondary end point of positive surgical margin, included in the analysis as a surrogate variable for oncologic safety, was based on the clinical record form alternatives of no information, negative, focal, extensive, or other. In the analysis, we combined focal and extensive into positive surgical margin status.
Statistical analysis
After interim analysis, group sizes were set at 700 patients in the RRP group and 1400 in the RALP group to yield 80% power to detect an absolute difference of 5%, based on a significance level of 0.05 and a twosided test, under the assumption that urinary incontinence after RRP would be 10-18%. As measures of effect, we report unadjusted relative risk ratios (RRs), calculated with log-binomial regression models and, due to lack convergence of log-binomial models, unadjusted and adjusted odds ratios (ORs) calculated with logistic regression models (Supplementary Table 1c ).
Results
Demography
Of 2625 eligible men, 2431 (93%) could be assessed for the primary end point (Fig. 1) . Return of the clinical record forms varied from 97% to 99%, and response rate for questionnaires ranged from 89% to 99%. Preoperative tumour characteristics did not differ significantly between the groups, except that clinical stage T2 tumours were more frequent in the RALP group than in the RRP group, and the total number of biopsies was higher in the RRP group than in the RALP group (Table 3) . Patients undergoing RALP had higher educational levels, higher American Society of Anesthesiologists classification scores, and lower body mass index values than patients in the RRP group (Table 3) . The skin-to-skin operative time was significantly longer for RALP, as was total time in the operating room. Significantly more patients underwent neurovascular bundle preservation during RALP, and significantly more lymph node dissections were made during RRP. Perioperative bleeding was less and the length of hospital stay was shorter in the RALP group (Table 3) . There was no significant difference between groups regarding frequencies of treatment with radiation or endocrine substances at 12 mo after surgery. 
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3.2.
Urinary incontinence
The following variables occurred in 34 of the 50 imputed models and were selected as possible confounders: age, diabetes mellitus, mental disorder, history of abdominal surgery, prostate weight, pulmonary disease, and employment status. When adjusted for possible confounders, no statistically significant difference in ORs was found between groups for any definition of urinary incontinence, as the 95% CIs for all ORs covered unity ( Table 1 ). The adjusted OR of urinary incontinence as defined for the primary analysis (at least one pad changed per 24 h) at 12 mo was 1.21 (95% CI, 0.96-1.54), and the 95% CIs for the ORs comparing any frequency of changing pads covered unity (Table 1a) . When the additional questions concerning details of urinary leakage and discomfort were taken into account, the proportions of patients classified as having urinary incontinence ranged from 20% to 56% after RRP and from 21% to 57% after RALP, with the higher frequencies found when we assessed urinary incontinence by a combination of not pad-free and not leakage-free (Table 1b) .
A sensitivity analysis of influence of including centre, calculating unadjusted RRs withdrawing one centre at a time, did not result in any significant difference among centres. The effects of preoperative tumour characteristics on urinary incontinence (Table 1b) resulted in ORs ranging from 1.32 to 0.95, and all 95% CI values covered 1.0, regardless of the definition of urinary incontinence used, indicating that this contrast was not significant. The definition used for the primary end point resulted in an OR of 1.31 (95% CI, 1.01-1.70) after adjustment for background factors, tumour characteristics, and neurovascular preservation (Table 1b) . The ORs for other definitions of incontinence all had 95% CIs covering 1.0 after adjustment, indicating that there were no statistically significant differences between the two techniques.
Erectile dysfunction
The following confounding variables (occurring in 42 of 50 imputed models) were selected as possible: age at surgery, educational level, smoking status, employment status 12 mo after surgery, and history of cardiovascular disease. After adjustment, the OR for any erectile dysfunction was 0.80 (95% CI, 0.64-1.00) ( Table 2 ). Classification of erectile dysfunction by different definitions did not substantially affect the ORs (Table 2 ). When adjustments were made for the preoperative clinical tumour characteristics, OR was 0.74 (95% CI, 0.59-0.95); the neurovascular preservation OR was 0.75 (95% CI, 0.58-0.96) ( Table 2) ; and adjusting for lymph node dissection resulted in an OR of 0.78 (95% CI, 0.61-1.00).
Positive surgical margin
Of the possible confounders, only prostate weight was carried through to the final analysis. The frequencies of positive surgical margin were 22% and 21% for RALP and RRP, respectively (Table 4) , and the unadjusted and adjusted RRs and ORs all had 95% CIs covering 1.0.
Discussion
This large, prospective, controlled, nonrandomised trial to evaluate outcomes of RALP in comparison with RRP showed no statistically significant difference regarding the primary end point: patient-reported urinary incontinence 12 mo after surgery. However, for erectile dysfunction 12 mo after the operation, fewer patients were affected after RALP than after RRP. The surgical approach made no difference in the rate of positive surgical margins, a surrogate marker for oncologic outcome.
Hu and coworkers performed a registry-based study of reimbursement claims for urinary incontinence after minimally invasive RP, including RALP [7] . Their propensity model-adjusted figures were 15.9 per 100 personyears for minimally invasive surgery and 12.2 for RRP, which resulted in a ratio of reimbursement claims of 1. 30 (95% CI, 1.05-1.61) . In contrast, we based our analyses of urinary incontinence on patients' self-reported experiences of urinary incontinence. All procedures in our study were performed by surgeons who had performed 100 procedures, whereas Hu and coworkers did not take surgeon experience into account. We found no statistically significant difference regarding incontinence when comparing RALP and RRP. A recent report on learning curve found a surgeon ''break-even point'' regarding urinary continence of 182 cases [12] .
Several reports have been published on single-institution case series [28] [29] [30] , in which selection-induced problems leading to confounding by indication might compromise the interpretation when comparing two simultaneously performed techniques because of surgeon and/or patient preferences. Patient selection by the surgeon may imply that more complex cases with higher risk of untoward results would not be included, resulting in better outcomes, whereas a selection of treatment modality by the patient may be due to an assumption of results of the chosen procedure, which could influence the patients' perception of outcomes postoperatively. Ahlering et al found no difference in urinary incontinence at 3 mo postoperatively [28] , whereas Ficarra et al reported a significantly better continence at 12 mo after RALP compared with RRP [29] . With the design of our trial, unaccounted-for problems induced by selection should be small, and our result-finding no statistically significant difference in urinary incontinence between the two techniques-should accurately reflect practice in Sweden at the time. When Barry et al assessed data from a national registry asking patients about urinary incontinence after RALP or RRP, they found no statistically significant difference in outcomes between techniques [30] .
We suggest that in the future, the appropriate definition of urinary incontinence from the patient's perspective should be not pad-free and not leakage free, as indicated when taking the patient's bother into account [26] .
In our study, RALP resulted in a statistically significantly higher proportion of men (30%) with erectile function 12 mo after surgery than did RRP (25%), but the majority of the men in the two groups experienced negative effects on sexual health. Hu and coworkers reported 26.8 reimbursement claims per 100 person-years for erectile dysfunction after minimally invasive surgery and 19.2 for open surgery, which gives an OR of 1.40 (95% CI, 1.14-1.72) [7] . Their definition of erectile dysfunction is quite different from that used in our study, which is probably an important reflection of the differences in frequencies; the method and 
definition we used should reflect the reality more closely. The high level of erectile dysfunction reported in our study is most probably explained by the use of validated questionnaires sent to a third party, the high answering rates, and the population basis for the cohort. In comparison to a recent report from a highly specialised tertiary referral centre [17] , the rates of erectile dysfunction in our trial are higher, but there are noteworthy differences in answering rates (at most, 62% vs >90% in our trial), apart from the unknown effect of referral as such. A metaanalysis of six comparative studies reported better return to sexual health after RALP than after RRP at 12 mo, with an OR of 2.84 (95% CI, 1.46-5.43) [31] . We found a small but statistically significant difference in favour of RALP (70%) versus RRP (75%), and that difference persisted after using various definitions of erectile dysfunction and after adjustments. However, the absolute difference of 5% was modest. The health-economic analysis, which is part of our trial protocol and still to be performed, will be of considerable interest. For valid comparisons among studies, the definitions of urinary incontinence and erectile dysfunction, ideally, should be identical. In our study, we were able to use a number of definitions by asking several questions and found consistent results for comparisons of the two techniques, and we conclude that the results are robust.
Self-reported data can vary in validity depending on whether questionnaires are returned to a neutral third party instead of the centre responsible for the surgery [13, 14] . Significant differences regarding urinary incontinence comparing interviews in the clinical setting with questionnaires have been reported [15] . We chose questionnaires and central administration to ensure that contacting, sending, and reminding were uniform and to avoid patient dependency.
The strengths of our study include the prospective controlled design; the sample size; the short inclusion period; the high participation and response rates; the experience of the surgeons; the collection of information before, during, and after surgery; and the use of validated measures. A concern before start of the study was that the lack of randomisation could lead to an imbalance between groups for important risk factors for urinary incontinence. This imbalance was counteracted by collection of information about possible risk factors and use of this information for adjustments during analyses. The modest changes in RRs and ORs after adjustments indicate that the residual confounding effects of lack of randomisation (selectioninduced problems) are small, if any, with regard to the assessment of the primary end point. The case volumes of the surgeons and the centres might influence the rates of urinary incontinence and erectile dysfunction at 12 mo. The effect of surgeon experience on outcome in terms of recurrence has been described by Vickers et al [32] , and this variable as well as functional outcomes are of interest from a planning perspective in national health care systems and for individual patients. An analysis of this aspect within the framework of this trial, including initial experience, is planned. In this analysis, our aim was to study the mean competence at the time in Sweden for the respective techniques at the experience level of 100 operations.
Conclusions
Earlier suggestions of improved erectile function, although modest, after RALP were substantiated, whereas improvement of urinary continence was not. Acknowledgments: Gunnar Steineck was the deputy principal investigator. We thank Dr. Sven Grundtman for including patients in the trial.
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